Posted inWire
COVAXX and Aurobindo Pharma announce COVID-19 vaccine partnership
Agreement leverages Aurobindo Pharma’s existing development, commercial and manufacturing infrastructure HAUPPAUGE: COVAXX, a U.S. company developing UB-612 a multitope peptide-based vaccine to fight COVID-19, announced an exclusive agreement with Aurobindo…